MStranslate logo
Log In
Lost your password?
Lost Password
Back to login
Search
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us
Breaking
  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast - Episode Library
  • Patient Community Day at ECTRIMS 2025
  • Multiple Sclerosis in 2025 – Key Developments to Date
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us

Author MStranslate

MStranslate

Novoron Bioscience

Novoron Bioscience: Remyelination Research

MStranslate
May 16, 2022
Dr Travis Stiles, Remyelination, Research
In the past, our co-founder, Brett Drummond, and MStranslate partner, Dr Travis Stiles, have talked broadly about developments in remyelination research around the world.  However, they have never really...
Dr Barry Singer

ACTRIMS Forum 2022 Insights – Dr Barry Singer

MStranslate
April 4, 2022
ACTRIMS, Conferences, Research
The Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) held its annual meeting between February 24 and 26 in West Palm Beach, Florida.  Unfortunately, due to ongoing travel...
milk multiple sclerosis

Does Drinking Cow’s Milk Worsen MS Symptoms?

MStranslate
March 10, 2022
Diet, Research, Symptoms
A new study from the University of Bonn has investigated whether a protein found in cow's milk can lead to damage of the central nervous system. In the below research summary video, our co-founder, Brett...
Wahls Protocol

Study Compares Wahls & Swank Diets in MS

MStranslate
January 29, 2022
Diet, Research
Written by Brett Drummond (MStranslate co-founder), in collaboration with Joey Lambert (MStranslate intern) The impact of diet on the quality of life of a person living with multiple sclerosis (MS) is of...
Epstein-Barr virus and multiple sclerosis

Is Epstein-Barr Virus the Cause of Multiple Sclerosis?

MStranslate
January 17, 2022
Epstein-Barr virus, Research
A new study from Harvard University has provided more evidence supporting a link between Epstein-Barr virus (EBV) infection and multiple sclerosis. In the video below, MStranslate co-founder and chief...
COVID-19 vaccine

Multiple Sclerosis and the COVID-19 Vaccine

MStranslate
January 12, 2022
COVID-19, Dr Sally Shaw, Infection
5 Comments
UPDATED I don’t think it would be much of a stretch to say that the last two years have been dominated by the coronavirus pandemic.  In a continually changing environment, we have recognised the need to...
AHSCT

Real World Application of AHSCT in MS

MStranslate
December 22, 2021
Research, Stem Cells, Treatments
Written by Brett Drummond (MStranslate co-founder), in collaboration with Joey Lambert (MStranslate intern) Autologous haematopoietic stem cell transplantation (AHSCT) is an exciting, recently developed...
Surplus Suffering

Surplus Suffering in MS: An Exclusive Interview

MStranslate
December 16, 2021
Dr Sally Shaw, Research, Videos
While MStranslate has been built upon a desire to report on the latest developments in multiple sclerosis research as they occur, we are also committed to sharing and illuminating the lived experience of MS....
remyelination

Latest Remyelination Research Developments in MS

MStranslate
November 24, 2021
Dr Travis Stiles, ECTRIMS, Remyelination, Research, Videos
In his first feature as an official member of the MStranslate team, Novoron Bioscience CEO, Dr Travis Stiles, recently sat down with our co-founder, Brett Drummond, to discuss the latest developments in...
ECTRIMS Congress 2021

ECTRIMS Congress 2021: Research Insights

MStranslate
October 18, 2021
Conferences, Dr Travis Stiles, ECTRIMS, Research, Videos
Due to the ongoing challenges and restrictions of the COVID-19 pandemic, ECTRIMS Congress 2021 was once again held as a virtual conference this year.  Taking place between October 13 and 15, this meeting...
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

Posts

  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast – Episode Library
  • Patient Community Day at ECTRIMS 2025

Google+

Get social

Copyright 2014-2018 MStranslate. All Rights Reserved. Contact Us
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.